Expression of angiogenic factors Cyr61 and tissue factor in uveal melanoma

Archives of Ophthalmology

Volumn 120, Issue 12, 2002, Pages 1719-1725

  Walker, Teresa M ^a   Van Ginkel, Paul R ^a   Gee, Ricardo L ^a   Ahmadi, Hoda ^a   Subramanian, Lalita ^a   Ksander, Bruce R ^c   Meisner, Lorraine F ^b   Albert, Daniel M ^a   Polans, Arthur S ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b WISCONSIN STATE LABORATORY OF HYGIENE   (United States)

^c SCHEPENS EYE RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; ANGIOGENIC FACTOR CYR61; THROMBOPLASTIN; UNCLASSIFIED DRUG;

ARTICLE; BLOOD VESSEL DIAMETER; CHROMOSOME 1P; EYE TUMOR; GENE DUPLICATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MICROCIRCULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE; TUMOR VASCULARIZATION; UVEA MELANOMA;

EID: 0036967673     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.120.12.1719     Document Type: Article

References (42)

1. Seddon JM, Egan KM, Gragoudas ES. Epidemiology of uveal melanoma. In: Ryan SJ, ed. Retina. St Louis: Mosby-Year Book Inc; 1989:639-646.
2. Kath R, Hayungs J, Bornfeld N, Sauerwein W, Hoffken K, Seeber S. Prognosis and treatment of disseminated uveal melanoma. Cancer. 1993;72:2219-2223.
3. Bedikian AY, Legha SS, Mavligit G, et al. Treatment of uveal melanoma metastatic to the liver. Cancer. 1995;76:1665-1670.
4. Holly EA, Aston DA, Ahn DK, Smith AH. Intraocular melanoma linked to occupations and chemical exposures. Epidemiology. 1996;7:55-61.
5. Foss AJE, Dolin PJ. Trends in eye cancer mortality among adults in the USA and England and Wales. Br J Cancer. 1996;74:1687-1689.
6. Albert DM. The ocular melanoma story: LIII Edward Jackson Memorial Lecture: part II. Am J Ophthalmol. 1997;123:729-741.
7. Albert DM, Ryan LM, Borden EC. Metastatic ocular melanoma: a comparison of patient characteristics and prognosis. Arch Ophthalmol. 1996;114:107-108.
8. Folberg R, Pe'er J, Gruman LM. The morphologic characteristics of tumor blood vessels as a marker of tumor progression in primary human uveal melanoma: a matched case-control study. Hum Pathol. 1992;23:1298-1305.
9. Rummelt V, Folberg R, Rummelt C, et al. Microcirculation architecture of melanocytic nevi and malignant melanomas of the ciliary body and choroid: a comparative histopathologic and ultrastructural study. Ophthalmology. 1994;101: 718-727.
10. Makitie T, Summanen P, Tarkkanen A, Kivela T. Microvascular density in prediciting survival of patients with choroidal and ciliary body melanoma. Invest Ophthalmol Vis Sci. 1999;40:2471-2480.
11. Makitie T, Summanen P, Tarkkanen A, Kiveal T. Microvascular loops and networks as prognostic indicators in choroidal and ciliary body melanomas. J Natl Cancer Inst. 2000;91:359-367.
12. Castella AP, Bercher L, Zografos L, Egger E, Herbort CP. Study of the blood-aqueous barrier in choroidal melanoma. BrJ Ophthalmol. 1995;79:354-357.
13. Vinores SA, Küchle M, Mahlow J, Chiu C, Green WR, Campochlaro PA. Blood-ocular barrier breakdown in eyes with ocular melanoma: a potential role for vascular endothelial growth factor vascular permeability factor. Am J Pathol. 1995; 147:1289-1297.
14. Huang X, Molema G, King S, Watkins L, Edgington TS, Thorpe PE. Tumor infarction in mice by antibody-directed targeting of tissue factor to tumor vasculature. Science. 1997;275:547-550.
15. Kim KJ, Li B, Winer J, et al. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo. Nature. 1993;362:841-844.
16. Hu Z, Garen A. Targeting tissue factor on tumor vascular endothelial cells and tumor cells for immunotherapy in mouse models of prostatic cancer. Proc Natl Acad Sci U S A. 2001;98:12180-12185.
17. Clark AF, Mellon J, Li X-Y, et al. Inhibition of intraocular tumor growth by topical application of the angiostatic steroid anecortave acetate. Invest Ophthalmol Vis Sci. 1999;40:2158-2162.
18. Yang GP, Lau LF. Cyr61, product of a growth factor-inducible immediate early gene, is associated with the extracellular matrix and the cell surface. Cell Growth Differ. 1991;2:351-357.
19. Babic AM, Kireeva ML, Kolesnikova TV, Lau LF. Cyr61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth. Proc Natl Acad Sci USA. 1998;95:6355-6360.
20. vβ3, independent of its carboxyl-terminal domain. J Biol Chem. 2001;276: 21943-21950.
21. Carmeliet P, Collen D. Molecules in focus: tissue factor. Int J Biochem Cell Biol. 1998;30:661-667.
22. Carmeliet P, Collen D. Gene manipulation of the plasminogen and coagulation system in mice. Semin Thromb Hemost. 1996;22:525-542.
23. Rosen ED, Chan J, Idusohe E, et al. Factor VII deficient mice develop normally but suffer fatal perinatal bleeding. Nature. 1997;390:290-294.
24. Kakkar AK, Lemoine NR, Scully MF, Tebbutt S, Williamson RC. Tissue factor expression correlates with histological grade in human pancreatic cancer. Br J Surg. 1995;82:1101-1104.
25. Contrino J, Hair G, Kreutzer DL, Rickles FR. In situ detection of tissue factor in vascular endothelial cells: correlation with the malignant phenotype of human breast disease. Nat Med. 1996;2:209-215.
26. Hamada K, Kuratsu J, Saitoh Y, Takeshima H, Nishi T, Ushio Y. Expression of tissue factor correlates with grade of malignancy in human glioma. Cancer. 1996; 77:1877-1883.
27. Bromberg ME, Konigsberg WH, Madison JF, Pawashe A, Garen A. Tissue factor promotes melanoma metastasis by a pathway independent of blood coagulation. Proc Natl Acad Sci U S A. 1995;92:8205-8209.
28. Zhang Y, Deng Y, Luther T, et al. Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice. J Clin Invest. 1994; 94:1320-1327.
29. Hu D, McCormick SA, Ritch R, Pelton-Henrion K. Studies of human uveal melanocytes in vitro: isolation, purification and cultivation of human uveal melanocytes. Invest Ophthalmol Vis Sci. 1993;34:2210-2219.
30. Chen PW, Murray TG, Uno T, Salgaller ML, Reddy R, Ksander BR. Expression of MAGE genes in ocular melanoma during progression from primary to metastatic disease. Clin Exp Metastasis. 1997;15:509-518.
31. Diatchenko L, Lau YC, Campbell AP, et al. Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries. Proc Natl Acad Sci U S A. 1996;93:6025-6030.
32. van Ginkel PR, Hauswirth WW. Parallel regulation of fetal gene expression in different photoreceptor cell types. J Biol Chem. 1994;269:4986-4992.
33. Doyle GA, Bourdeau-Heller JM, Coulthard S, Meisner LF, Ross J. Amplification in human breast cancer of a gene encoding a c-myc mRNA-binding protein. Cancer Res. 2000;60:2756-2759.
34. Ben-Ezra J, Johnson DA, Rossi J, Cook N, Wu A. Effect of fixation on the amplification of nucleic acids from paraffin-embedded material by the polymerase chain reaction. J Histochem Cytochem. 1991;39:351-354.
35. Stanta G, Schneider C. RNA extracted from paraffin-embedded human tissues is amenable to analysis by RCR amplification. Biotechniques. 1991;11:304-308.
36. Finke J, Fritzen R, Ternes P, Lange W, Dolken G. An improved strategy and a useful housekeeping gene for RNA analysis from formalin-fixed, paraffin-embedded tissues by PCR. Biotechniques. 1993;14:448-453.
37. Stanta G, Bonin S. RNA quantitative analysis from fixed and paraffin-embedded tissues: membrane hybridization and capillary electrophoresis. Biotechniques. 1998;24:271-276.
38. Martinerie C, Viegas-Pequignot E, Nguyen VC, Perbal B. Chromosomal mapping and expression of the human cyr61 gene in tumour cells from the nervous system. Mol Pathol. 1997;50:310-316.
39. Aiello LP. Vascular endothelial growth factor and the eye: biochemical mechanisms of action and implications for novel therapies. Ophthalmic Res. 1997;29:354-362.
40. Stitt AW, Simpson DAC, Boocock C, Gardiner TA, Murphy GM, Archer DB. Expression of vascular endothelial growth factor (VEGF) and its receptors is regulated in eyes with intra-ocular tumours. J Pathol. 1998;186:306-312.
41. Sheidow TG, Hooper PL, Crukley C, Young J, Heathcote JG. Expression of vascular endothelial growth factor in uveal melanoma and its correlation with metastasis. Br J Ophthalmol. 2000;84:750-756.
42. Maniotis AJ, Folberg R, Hess A, et al. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol. 1999;155: 739-752.